MedTrace Logo

PK Study With Pantoprazole in Obese Children and Adolescents

NCT02186652 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2019-09-17

Study results available
· View outcomes & findings →

Summary

Multicenter, comparative single-dose pharmacokinetic (PK) study

Conditions

  • Gastroesophageal Reflux Disease

Interventions

DRUG

Pantoprazole

Sponsors & Collaborators

  • The Emmes Company, LLC

    collaborator INDUSTRY

  • Phillip Brian Smith

    lead OTHER

Principal Investigators

  • Phillip B Smith, MD · Duke Clinical Research Institute

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-04
Primary Completion
2015-09-13
Completion
2015-09-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02186652 on ClinicalTrials.gov